The collaboration will leverage Medi Assist’s proprietary technology to streamline claims processing, enhance transparency, and deliver smarter health benefits to policyholders in the region
VievePharm is renowned for its phytogenic formulations across livestock, equine, and pet care markets
Emcure to distribute Roche's kidney transplant and anemia drugs in India
Under the deal, Vivtex will license select oral drug-delivery technologies to Novo Nordisk
Asahi Kasei Pharma receives worldwide exclusive rights for the research, development, manufacturing, and marketing of the active ingredients
Arcellx develops innovative immunotherapies for cancer and other incurable diseases
New partnership combines Shilpa Biologicals’ development and manufacturing capabilities with SteinCares’ regional commercialization platform
Meenal brings in more than 16 years of international experience across Europe, Asia and the Middle East
Under the deal, Quiver will receive an undisclosed advance payment and research support
Merck is currently conducting approximately 80 Phase 3 studies, and the company expects more than 20 new growth drivers over next several years, almost all with blockbuster potential
Subscribe To Our Newsletter & Stay Updated
